Kate Ryder was ahead of her time when, in 2014, she founded Maven Clinic. She weathered dozens of rejections from investors who didn’t understand the need for a 24/7, on-demand, comprehensive reproductive health care platform. But Kate plowed ahead, fueled by her certainty that women’s health care wasn’t a niche market. Her truly pioneering move was to start working with businesses, including Bumble, allowing companies to support employees’ seeking access to a whole spectrum of reproductive-health and family-planning services. What could be more critical for businesses right now, with the health care rights of half their workforces under siege? Kate’s foresight has also had a monumental knock-on effect: thanks to Maven’s care, more women are able to succeed at work. Today, Maven is valued at over $1 billion—the only U.S. company focused on women’s health care to reach this milestone. Am I surprised at its ascent? Not at all. It just took a while for the market to catch up with Kate Ryder.
More from TIME
Wolfe Herd is founder and CEO of Bumble
- Why Trump’s Message Worked on Latino Men
- What Trump’s Win Could Mean for Housing
- The 100 Must-Read Books of 2024
- Sleep Doctors Share the 1 Tip That’s Changed Their Lives
- Column: Let’s Bring Back Romance
- What It’s Like to Have Long COVID As a Kid
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision
